Objective: The purpose of this study was to evaluate the efficacy of acupressure at the P6 point for the in- patient treatment of severe nausea and vomiting in early pregnancy. Study design: This was a prospective sin...Objective: The purpose of this study was to evaluate the efficacy of acupressure at the P6 point for the in- patient treatment of severe nausea and vomiting in early pregnancy. Study design: This was a prospective single- blind randomized control trial that involved 80 patients with nausea and vomiting plus ketonuria before 14 weeks of gestation. Results: There was no difference between length of stay, amount of medication, or fluid required between the acupressure and placebo groups, although acupressure reduced the number of patients who stayed ≥ 4 nights in the hospital. Acupressure was well tolerated and not associated with an increase in perinatal morbidity or death. Conclusion: The use of acupressure at the P6 point does not reduce the amount of antiemetic medication that is required, the requirement for intravenous fluid, and median duration of in- patient stay more than the use of placebo. A small reduction was seen in the number of women who required ≥ 4 days in the hospital.展开更多
文摘Objective: The purpose of this study was to evaluate the efficacy of acupressure at the P6 point for the in- patient treatment of severe nausea and vomiting in early pregnancy. Study design: This was a prospective single- blind randomized control trial that involved 80 patients with nausea and vomiting plus ketonuria before 14 weeks of gestation. Results: There was no difference between length of stay, amount of medication, or fluid required between the acupressure and placebo groups, although acupressure reduced the number of patients who stayed ≥ 4 nights in the hospital. Acupressure was well tolerated and not associated with an increase in perinatal morbidity or death. Conclusion: The use of acupressure at the P6 point does not reduce the amount of antiemetic medication that is required, the requirement for intravenous fluid, and median duration of in- patient stay more than the use of placebo. A small reduction was seen in the number of women who required ≥ 4 days in the hospital.
